Hong Kong Pharmacy Bachelor Complete Guide 2026: HKU JS6494, CUHK JS4525, Four-Year BPharm, Pharmacy and Poisons Board Registration, Hospital Authority Pharmacist Salary Scales
Only two universities in Hong Kong currently offer a UGC-funded Bachelor of Pharmacy (BPharm) degree: The Chinese University of Hong Kong School of Pharmacy (JUPAS code JS4525) and The University of Hong Kong Department of Pharmacology and Pharmacy (JUPAS code JS6494). Both programmes run for four years full-time, both are accredited by the Pharmacy and Poisons Board of Hong Kong (PPBHK), and graduates of both — after passing the Board’s registration examination and completing a one-year approved internship — are eligible to register as practising pharmacists in Hong Kong’s public hospitals, private hospitals, community pharmacies (the registered counters at Mannings, Watsons, and CRC Care), pharmaceutical manufacturing, regulatory affairs, and academic research.
Pharmacy is one of the few healthcare degrees in Hong Kong with effectively 100% graduate employment. The Hospital Authority pharmacy departments have been expanding for several years, the 2024 amendments to the Pharmacy and Poisons Ordinance have widened pharmacist scope of practice, and the gradual rollout of the prescription-dispensing model in community pharmacies has created persistent vacancies. This guide breaks down both programmes in detail — admissions, curriculum, the registration pathway, salary, and overseas mobility — to help 2026 DSE candidates make informed JUPAS Band A choices.
1. Why pharmacy is a stable choice in Hong Kong
1.1 Statutory foundation — the Pharmacy and Poisons Ordinance (Cap. 138)
Under Cap. 138 of the laws of Hong Kong, only individuals registered with the Pharmacy and Poisons Board of Hong Kong (PPBHK) may practise as pharmacists in Hong Kong. To be entered on the Register of Pharmacists, an applicant must:
- Hold a Board-recognised pharmacy degree;
- Pass the Pharmacist Registration Examination administered by the Board;
- Complete a Board-approved internship of at least one year;
- Satisfy character and fitness checks, and pay the registration fee.
A registered pharmacist must also obtain an Annual Practising Certificate at the start of each calendar year before lawfully practising. Without registration, an individual cannot dispense Part 1 poisons (most prescription medicines), supervise a registered pharmacy, or sign a methadone dispensing record.
1.2 Why a local BPharm is the cleanest entry route
The PPBHK does recognise certain overseas pharmacy degrees (UK MPharm, Australian BPharm/MPharm, Canadian PharmD, etc.), but overseas-trained graduates still need to sit and pass the Hong Kong Registration Examination, which has historically pegged pass rates at around 50% per paper. By contrast, BPharm graduates of HKU and CUHK take the same examination but with a curriculum tailored to Hong Kong’s drug schedules, dispensing law, and Cantonese-language patient counselling. Both schools also embed Board-approved internship rotations into the final year, so by graduation candidates are typically only a few months of further internship away from full registration. This is the cleanest route for any local DSE student set on a pharmacy career in Hong Kong.
2. Programme snapshot
| Item | HKU BPharm (JS6494) | CUHK BPharm (JS4525) |
|---|---|---|
| Awarding faculty | LKS Faculty of Medicine, Department of Pharmacology and Pharmacy | Faculty of Medicine, School of Pharmacy |
| Duration | 4 years, full-time, 258 credit-units | 4 years, full-time |
| Annual intake | ~35 first-year places | ~30 first-year places |
| Degree | Bachelor of Pharmacy (BPharm) | Bachelor of Pharmacy (Honours) |
| Accreditation | Pharmacy and Poisons Board of Hong Kong | Pharmacy and Poisons Board of Hong Kong |
| Teaching sites | Sassoon Road Campus; Queen Mary Hospital; Gleneagles Hong Kong Hospital | Lo Kwee-Seong Integrated Biomedical Sciences Building (Sha Tin); Prince of Wales Hospital |
| Internship structure | Pharmacy Experiential Education Programme (PEEP) embedded across years | Clinical clerkships in Year 4; one-year post-graduation internship typical |
| Tuition (local students) | HK$44,500 / year (UGC-funded rate) | HK$44,500 / year (UGC-funded rate) |
Combined intake across the two universities is roughly 65 places per year — fewer than dentistry (90 BDS places at HKU) and far fewer than the ~590 MBBS/MBChB seats. This makes pharmacy one of the smaller and tighter healthcare cohorts in Hong Kong.
3. JUPAS admission requirements
3.1 General DSE requirement (both universities)
Both HKU and CUHK require the standard “3-3-2-2-3-3” minimum to be considered: Level 3 in Chinese Language, Level 3 in English Language, Level 2 in Mathematics Compulsory Part, Level 2 in Citizenship and Social Development, and Level 3 in two elective subjects.
For pharmacy, however, hitting the floor is nowhere near enough. Both schools weight Chemistry and Biology as effective prerequisites, and successful applicants typically present Level 5 to 5* averages across the four core plus two best electives.
3.2 Subject combination expectations
- Chemistry is treated as a de-facto prerequisite at both universities. Without Chemistry it is extremely difficult to be shortlisted, and impossible to follow the first-year pharmaceutical chemistry curriculum.
- Biology is strongly preferred as the second science elective. Students who present Physics or Mathematics M1/M2 instead are not strictly excluded, but Biology applicants tend to fare better in interview because the curriculum builds rapidly into anatomy, physiology and pharmacology.
- Mathematics Extended Module M1 or M2 can be counted as the seventh subject in HKU’s “best 6 subjects” formula and CUHK’s flexible weighting, and is useful for pharmacokinetics calculations later on.
3.3 Indicative admission scores (2024–2025 entry, for 2026 reference)
Best-six DSE scores for the median admitted student have hovered around:
- HKU JS6494: median ~33 – 34 (best 6, 4-2-2-2-2-2 weighting, with science subjects at full weight)
- CUHK JS4525: median ~33 – 35 (best 5 weighted on the relevant subject formula, with bonus for Chemistry)
The lower-quartile admit is typically around 30–31 for both. Realistically, Band A applicants should aim for 5 or 5* in Chemistry and Biology plus 5* in English to be safely competitive, since both schools interview shortlisted candidates.
3.4 Interviews
- HKU runs group discussion + short individual interview, conducted in English, focused on ethical scenarios, communication, and motivation. Topics commonly include drug pricing, generic substitution, medication safety, and the role of community pharmacy.
- CUHK uses a similar group + individual format and is also conducted in English with some Cantonese sections to test patient-counselling potential. Expect questions on local healthcare policy and on why CUHK rather than HKU.
Strong candidates spend serious time before the interview reading the Department of Health drug office circulars, the Consumer Council medication articles, and the Hospital Authority Drug Formulary news.
4. Four-year curriculum structure
4.1 HKU BPharm
HKU’s 258-credit programme is structured as follows:
- Year 1 — Foundations: General chemistry, organic chemistry, human anatomy and physiology, introduction to pharmacy practice, communication skills, and a common-core curriculum of HKU general education courses.
- Year 2 — Pharmaceutical sciences: Pharmaceutical chemistry, pharmaceutics (formulation), pharmacology I, biochemistry, microbiology and immunology.
- Year 3 — Clinical and applied: Clinical pharmacy, pharmacotherapeutics across body systems, pharmacokinetics, pharmacoepidemiology, drug regulatory affairs, and the start of the Pharmacy Experiential Education Programme (PEEP) placements.
- Year 4 — Capstone and clerkships: Advanced pharmacotherapeutics, hospital clerkships at Queen Mary and Gleneagles, community-pharmacy rotations, a research-based final-year project, and Hong Kong pharmacy law and ethics in preparation for the Board examination.
4.2 CUHK BPharm
CUHK’s curriculum follows a similar four-year arc but with somewhat heavier early emphasis on biomedical fundamentals (because the School of Pharmacy sits within the Faculty of Medicine and shares first-year basic science teaching with medicine and Chinese medicine students):
- Year 1: Core sciences shared with the medical faculty; introduction to pharmacy.
- Year 2: Drug discovery and design, medicinal chemistry, pharmaceutics, applied physiology.
- Year 3: Pharmacology and therapeutics, biopharmaceutics, clinical pharmacy I, drug information and patient counselling.
- Year 4: Clinical clerkships at Prince of Wales Hospital and selected community pharmacies, pharmacy management, research project, and law and ethics.
4.3 Experiential learning
Both programmes embed multiple weeks of supervised practice. HKU’s PEEP, for instance, places students in a structured rotation across hospital pharmacy, community pharmacy, and pharmaceutical industry settings, supervised by registered pharmacist preceptors. These placements do not by themselves satisfy the post-graduation one-year internship — they are educational rotations during the degree — but they significantly accelerate clinical confidence.
5. The Pharmacist Registration Examination
After graduation, both HKU and CUHK BPharm holders must sit the Pharmacist Registration Examination administered by the PPBHK to be eligible for full registration. Key facts:
- Three papers, each three hours: (1) Pharmacy Legislation, (2) Pharmacy Practice, (3) Pharmacology.
- Examination windows: Held twice a year, typically in June and December. Application deadlines for new entrants are 28 February (June sitting) and 31 August (December sitting). Re-sit deadlines are 31 March and 30 September respectively.
- Cohort size: Approximately 80–100 candidates per paper, drawn from local BPharm graduates and overseas-trained pharmacists.
- Pass rate: Roughly 50% per paper, on average. Pharmacy Legislation has historically been the most failed paper for overseas candidates because of the depth of Hong Kong-specific drug schedule and ordinance content.
After passing all three papers, the candidate must complete (or have completed) the one-year approved internship before being added to the Register of Pharmacists. Most local BPharm graduates start their internship immediately after graduation in a Hospital Authority pharmacy or a major community-pharmacy chain, sit the registration exams during or just after that year, and qualify within roughly 12–18 months of degree completion.
6. Career pathways and salary in Hong Kong
6.1 Hospital Authority — the largest employer
The Hospital Authority is by far the largest employer of pharmacists in Hong Kong, operating pharmacy departments across all 43 public hospitals and a centralised drug procurement and compounding unit.
- Resident Pharmacist (intern): Roughly HK$36,000 – HK$40,000 / month during the one-year internship year.
- Pharmacist I: Entry rank for fully registered pharmacists. Pegged at approximately Master Pay Scale Point 27, equivalent to roughly HK$60,000 / month in 2026. With incremental rises through the scale, mid-career Pharmacist I salaries reach Point 33+ within several years.
- Senior Pharmacist / Senior Pharmacist (Specialist): Mid-to-senior rank, MPS Point 34 onwards, typically reached within 6–10 years of registration depending on departmental vacancies.
- Department Manager / Chief Pharmacist: MPS Point 45+ at the top end of the Hospital Authority pharmacist career ladder.
The HA also has dedicated clinical pharmacy specialty tracks in oncology, infectious diseases, anticoagulation, total parenteral nutrition, and ambulatory care.
6.2 Department of Health and government
The Department of Health employs Pharmacists within the Drug Office (regulatory affairs, GMP inspection, clinical-trial certification) and the Government Pharmacist grade. Pay broadly tracks the Hospital Authority’s MPS pegging. The Drug Office pathway is typically chosen by graduates with an interest in regulatory science and pharmaceutical law rather than direct patient care.
6.3 Community pharmacy
Major community-pharmacy chains — Mannings, Watsons, the Hospital Authority Drug Formulary affiliated pharmacies, and the smaller registered-pharmacy operators — recruit BPharm graduates as store pharmacists at starting salaries of around HK$45,000 – HK$55,000 / month, often with retention bonuses to compensate for the salary gap with the Hospital Authority. Pharmacist-in-charge roles at flagship outlets reach HK$65,000+ within a few years.
The community-pharmacy sector is set to grow further as Hong Kong rolls out the Primary Healthcare Blueprint and the District Health Centre scheme, both of which assume a larger role for community pharmacists in chronic-disease management and minor ailment counselling.
6.4 Industry and other sectors
Beyond hospital and community practice, BPharm graduates also enter:
- Pharmaceutical industry: Regulatory affairs, medical affairs, drug safety/pharmacovigilance, and clinical research at the Hong Kong offices of multinational pharmaceutical firms.
- Academia and research: PhD pathways at HKU, CUHK, and overseas, often via the Hong Kong PhD Fellowship Scheme.
- Government and NGOs: Department of Health, Hospital Authority Head Office, Consumer Council, and HK Pharmacy Council secretariat.
Effectively all BPharm graduates are placed in a pharmacy-related role within months of graduation. Hong Kong has been classified as having a chronic pharmacist shortage by Hospital Authority workforce reviews for over a decade.
7. Overseas registration pathways
A Hong Kong BPharm degree is well-recognised internationally, but no jurisdiction grants automatic mutual recognition — every country requires additional examinations or supervised practice.
7.1 United Kingdom — General Pharmaceutical Council (GPhC)
The GPhC requires non-UK pharmacy graduates to complete the Overseas Pharmacist Assessment Programme (OSPAP) — a one-year postgraduate diploma at an accredited UK university — followed by the standard 52-week pre-registration training (Foundation Training Year) and the GPhC Registration Assessment. Total time-to-licence for a Hong Kong BPharm graduate is typically 2–3 years from arrival in the UK.
7.2 Australia — Australian Pharmacy Council (APC)
The APC operates a competency-based pathway. Hong Kong BPharm graduates apply for Skills Assessment, then complete an Australian internship (around 1,824 hours) under a registered preceptor, sit the Pharmacy Board of Australia oral and written examinations, and then register with AHPRA. Time-to-licence is around 1.5–2 years.
7.3 Canada — Pharmacy Examining Board of Canada (PEBC)
The PEBC operates an evaluation pathway that includes the Document Evaluation, Evaluating Examination, Qualifying Examination Part I (MCQ) and Part II (OSCE), plus structured practical training (length varies by province). Provincial regulators (e.g. OCP in Ontario) layer their own jurisprudence examinations on top. Time-to-licence is typically 2–4 years.
7.4 United States — NABP
US pharmacy is now a doctoral-entry profession (PharmD). A Hong Kong BPharm holder applies to the NABP FPGEC for the Foreign Pharmacy Graduate Equivalency Certificate, then sits the FPGEE and TOEFL iBT, completes US internship hours, and takes the NAPLEX plus state-specific MPJE jurisprudence exam. Most US states still effectively expect a PharmD for clinical roles, so many Hong Kong graduates aiming at the US instead go via a US PharmD bridge programme.
7.5 Singapore — Singapore Pharmacy Council (SPC)
The SPC accredits selected overseas pharmacy programmes and historically has been receptive to HKU and CUHK BPharm holders, who must still complete a Singapore pre-registration training programme and sit the SPC’s registration assessments. Time-to-licence is around 1–1.5 years.
7.6 Mainland China
Mainland China runs its own Licensed Pharmacist examination (执业药师). A Hong Kong BPharm graduate planning to practise across the border typically sits the mainland licensing examination, which is conducted in Chinese, and registers via the relevant provincial pharmaceutical administration. Career mobility into the Greater Bay Area is increasingly common, and CUHK Shenzhen has been signalling closer cross-boundary pharmacy collaboration.
8. HKU vs CUHK — how to choose
| Dimension | HKU JS6494 | CUHK JS4525 |
|---|---|---|
| Teaching language | Predominantly English | Predominantly English |
| Hospital base | Queen Mary, Gleneagles HK | Prince of Wales Hospital |
| Class size | ~35 | ~30 |
| Strengths | Drug discovery, pharmaceutical chemistry, longer-established department, deep links to Queen Mary | Clinical pharmacy emphasis, integrated biomedical campus, strong community-pharmacy linkages |
| Geography | Pok Fu Lam / Sassoon Road | Sha Tin |
| First-year experience | Common Core HKU general education; bigger broad-based campus feel | Faculty of Medicine common first year; tighter cohort within a focused medical campus |
Neither programme is “better” in absolute terms — both are PPBHK-accredited, both produce graduates who fully populate the Hospital Authority pharmacy departments, and both lead to identical professional registration. The honest practical questions for a 2026 candidate are:
- Which campus geography fits your home? Sha Tin vs Pok Fu Lam is a real one-hour-a-day commute difference for many students.
- Do you prefer a more discovery-and-chemistry feel (HKU) or a more clinical-faculty feel (CUHK)?
- Which interview format do you perform better in? Sit a mock interview with both styles before locking your Band A choice.
Most Band A applicants pick one as Band A1 and the other as A2 — that combination protects against single-school interview variance and is the standard strategy among 5** DSE candidates.
9. Application timeline for 2026 entry
| Date (approx.) | Action |
|---|---|
| Sep – early Dec 2025 | Open JUPAS account, submit programme choices |
| 4 Dec 2025 (deadline) | JUPAS Programme Choices initial deadline |
| Late Apr – mid May 2026 | DSE examinations |
| Late May 2026 (deadline) | JUPAS Programme Choices final amendment deadline |
| Mid-Jul 2026 | DSE results released |
| Late Jul 2026 | JUPAS Main Round offers; HKU and CUHK BPharm interviews held |
| Early Aug 2026 | Final pharmacy offers issued |
| Sep 2026 | Programme commences |
Both faculties typically interview in late July, immediately after results release. Block out the week after results day for interview preparation — it is too late to start preparing then if you have not already practised.
10. Final notes — is BPharm right for you?
Pharmacy in Hong Kong is a very stable, very specialised career. The trade-off is that the day-to-day work is more focused than medicine — you will not run a clinic and you will not perform surgery — but you will own the medication-safety and counselling layer of patient care, and you will build deep expertise in pharmacotherapy. Public-sector pharmacist hours are also dramatically more humane than HA medical officer rotations.
If you enjoy chemistry and biology equally, want a healthcare profession with a clear registration pathway and clear salary scale, and value work-life balance over the prestige of an MBBS letterhead, BPharm is a strong Band A choice for 2026. With only 65 places between HKU and CUHK, it is selective — but the funnel is narrower than medicine and the rewards (in employment certainty and overseas mobility) compare favourably.
For a deeper look at the JUPAS scoring formulas referenced above, see our JUPAS scoring and calculation complete guide. For comparison with other healthcare degrees in Hong Kong, see our complete guides to Nursing, Physiotherapy, Dental Surgery, and Speech-Language Pathology.